Is long-acting HIV treatment as good as taking daily pills?
A study published in 2018 gauged interest in potential new ARV therapies back then among 263 people with HIV from clinics in Duke and University of South Carolina.
North's First
North's First
A study published in 2018 gauged interest in potential new ARV therapies back then among 263 people with HIV from clinics in Duke and University of South Carolina.
Kindly write to us to copy and paste this article. Thank you!